Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NASDAQ
NASDAQ
Upstream swells IPO to $255M as it prepares to join Nasdaq along with CAMP4
Fierce Biotech
Fri, 10/11/24 - 09:32 am
Upstream Bio
IPOs
CAMP4 Therapeutics
NASDAQ
Cancer-focused Actuate is latest biotech on Nasdaq after $22.4M IPO
Fierce Biotech
Thu, 08/15/24 - 11:48 am
Actuate Therapeutics
IPOs
NASDAQ
AI medtech specialist Firefly lists on Nasdaq after merger
Pharmaphorum
Wed, 08/14/24 - 10:59 am
Medtech
Firefly Neuroscience
NASDAQ
WaveDancer
artificial intelligence
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win
BioSpace
Thu, 04/18/24 - 10:23 pm
Intra-Cellular Therapies
funding
NASDAQ
Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience
BioSpace
Wed, 11/15/23 - 11:58 am
Alkermes
spinoffs
oncology
Mural Oncology
NASDAQ
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO
Fierce Biotech
Fri, 09/22/23 - 11:42 am
AbPro
IPOs
SPAC
NASDAQ
Device company HDL Therapeutics eyes public listing in $480m SPAC deal
Pharmaphorum
Mon, 08/14/23 - 10:20 am
Medtech
SPAC
HDL Therapeutics
NASDAQ
atherosclerotic plaques
Okyo Pharma withdraws offer to sell shares after just 3 days citing 'changing market conditions'
Fierce Biotech
Mon, 07/31/23 - 11:38 am
Okyo Pharma
NASDAQ
Apogee, Sagimet overshoot IPO expectation as both biotechs land on Nasdaq
Fierce Biotech
Tue, 07/18/23 - 11:34 am
NASDAQ
IPOs
Apogee Therapeutics
Sagimet Biosciences
South Korean biotech group spies US SPAC as route to Nasdaq
Fierce Biotech
Wed, 07/12/23 - 09:46 am
OSR Holdings
South Korea
SPAC
NASDAQ
Turnstone Biologics Files for $86M IPO Amid Financial Difficulties
BioSpace
Wed, 06/14/23 - 10:09 am
Turnstone Biologics
IPOs
NASDAQ
Biotech consolidation continues as Nasdaq-listed Erytech merges with phage therapy developer
Endpoints
Thu, 02/16/23 - 10:29 am
Erytech
NASDAQ
Pferecydes
M&A
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Motley Fool
Wed, 01/18/23 - 09:50 am
Moderna Therapeutics
RSV
Bluebird Bio
NASDAQ
Elicio uses struggling Angion as route to Nasdaq ahead of cancer vaccine's phase 2 move
Fierce Biotech
Tue, 01/17/23 - 10:18 am
Elicio Therapeutics
NASDAQ
cancer vaccines
clinical trials
Angion Biomedica
GE’s board finalizes healthcare spinoff
Medtech Dive
Fri, 12/2/22 - 10:58 am
GE Healthcare
Medtech
NASDAQ
Three Biopharma Companies Heading to Nasdaq Through SPACs
BioSpace
Sun, 03/20/22 - 10:57 pm
SPACs
NASDAQ
Apexigen
Benuvia
Scilex
Vaccine Stocks Are Rising, but This Biotech Is Monday's Big Nasdaq Winner
Motley Fool
Mon, 12/20/21 - 10:57 am
biotech stocks
NASDAQ
vaccines
Novavax
Moderna Therapeutics
Ocugen
Intra-Cellular Therapies
Caplyta
Amylyx takes its ALS program to Nasdaq, raising the stakes for the biotech's only drug
Endpoints
Fri, 12/17/21 - 11:01 am
Amylyx
ALS
funding
NASDAQ
Italian cancer gene therapy biotech makes history with modest Nasdaq IPO
Endpoints
Thu, 12/16/21 - 11:08 am
gene therapy
IPOs
NASDAQ
Genenta
Italy
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Fierce Biotech
Thu, 11/11/21 - 11:03 am
Vaxxinity
IPOs
vaccines
immunotherapy
NASDAQ
Pages
1
2
3
4
5
6
7
next ›
last »